文献速递外周动脉疾病

全球肢体解剖分期系统(GLASS)对技术及肢体相关结局的可预测性:系统综述与Meta分析

Predictability of the Global Limb Anatomic Staging System (GLASS) for Technical and Limb Related Outcomes: A Systematic Review and Meta-Analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-04-11

该系统综述与Meta分析纳入7项回顾性队列研究和1项随机对照试验,共2204例患者(2483条肢体),评估GLASS分期与慢性肢体威胁性缺血(CLTI)患者血管内治疗(EVT)及旁路手术(BS)后结局的关系。汇总分析显示GLASS 1+2与GLASS 3在LSR和MALE上存在统计学差异,EVT亚组中差异显著而BS组无差异;GLASS 2和3中EVT后MALE显著更差。结论认为GLASS可预测LSR、MALE以及EVT后ITF和LBP,晚期GLASS分期支持优先选择BS而非EVT。

要点

  • GLASS 1+2与GLASS 3在LSR(HR 0.61)和MALE(HR 0.66)上存在统计学差异。
  • EVT亚组中GLASS 1+2与GLASS 3的AFS、LSR和MALE存在统计学差异,BS组无差异。
  • GLASS 1、2、3期EVT后ITF分别为3.9%、5.3%、27.9%。

核心结论

  • GLASS可预测LSR和MALE以及EVT后ITF和LBP。
  • 当前Meta分析提示晚期GLASS分期支持优先选择BS而非EVT。

研究设计与样本

  • 系统综述与Meta分析,按PRISMA指南进行,检索MEDLINE、Web of Science核心合集和Google Scholar至2021年6月。
  • 纳入7项回顾性队列研究和1项随机对照试验,共2204例患者(2483条肢体),比较按GLASS分期分层的CLTI患者结局。
  • 采用随机效应模型汇总数据。

主要发现

  • GLASS 1+2与GLASS 3在LSR上存在统计学差异(HR 0.61;95% CI 0.47 - 0.80,p < .001)。
  • GLASS 1+2与GLASS 3在MALE上存在统计学差异(HR 0.66;95% CI 0.53 - 0.83,p < .001)。
  • EVT亚组中GLASS 1+2与GLASS 3的AFS、LSR和MALE存在统计学差异,BS组无差异。
  • GLASS 2和3中EVT后MALE显著更差。
  • GLASS 1、2、3期EVT后ITF分别为3.9%、5.3%、27.9%;GLASS 1+2与GLASS 3的EVT后LBP存在统计学差异(HR 0.83;95% CI 0.71 - 0.97,p = .020)。

临床怎么用

  • 作者认为GLASS可预测LSR和MALE以及EVT后ITF和LBP。
  • 作者认为当前Meta分析提示晚期GLASS分期支持优先选择BS而非EVT。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The newly proposed Global Limb Anatomic Staging System (GLASS), a categorical staging of infrainguinal artery disease complexity, is expected to correlate with clinical outcomes in patients with chronic limb threatening ischaemia (CLTI). This study aimed to verify the relationship between GLASS stages and clinical outcomes after endovascular treatment (EVT) and bypass surgery (BS). DATA SOURCES: MEDLINE, Web of Science Core Collection, and Google Scholar were searched in consultation with a health sciences librarian through June 2021. REVIEW METHODS: This systematic review and meta-analysis was carried out according to the PRISMA guidelines. All studies comparing the outcomes of patients with CLTI stratified by GLASS staging were eligible. Amputation free survival (AFS), limb salvage rate (LSR), major adverse limb event (MALE), overall survival, immediate technical failure (ITF), and limb based patency (LBP) were analysed. Data were pooled and synthesised with a random effects model. RESULTS: Datasets from seven retrospective cohort studies and one randomised control trial with a total of 2 204 patients (2 483 limbs) were identified. Pooled estimates demonstrated statistical differences between GLASS 1+2 and GLASS 3 in LSR (HR 0.61; 95% CI 0.47 - 0.80, p < .001) and MALE (HR 0.66; 95% CI 0.53 - 0.83, p < .001). After stratification, there were statistical differences in AFS, LSR, and MALE between GLASS 1+2 and GLASS 3 in the EVT subgroup but not in BS. In GLASS 2 and 3, MALE was significantly worse after EVT. In GLASS stages 1, 2, and 3, ITF after EVT was 3.9%, 5.3%, and 27.9%, respectively. LBP after EVT was significantly different between GLASS 1+2 and GLASS 3 (HR 0.83; 95% CI 0.71 - 0.97, p = .020). CONCLUSION: GLASS is predictive of LSR and MALE as well as ITF and LBP after EVT. The current meta-analysis suggests advanced GLASS stages favour BS over EVT.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Shirasu T, Takagi H, Gregg A, et al. Predictability of the Global Limb Anatomic Staging System (GLASS) for Technical and Limb Related Outcomes: A Systematic Review and Meta-Analysis. Eur J Vasc Endovasc Surg. 2022. PMID: 35472449. doi:10.1016/j.ejvs.2022.03.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。